Aprea Therapeutics
APRE
APRE
19 hedge funds and large institutions have $2.78M invested in Aprea Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $3.77M → $2.78M (-$993K)
Holders
19
Holding in Top 10
–
Calls
$416K
Puts
–
Top Buyers
| 1 | +$74.3K | |
| 2 | +$13.5K | |
| 3 | +$7.25K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.82K |
| 5 |
MLA
MB, Levis & Associates
Center Valley,
Pennsylvania
|
+$2.54K |